Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi's Rimonabant: The Next Drug Safety Victim?

Related Content

Lost in Translation: Interpreting Advisory Committees

Mar 01 2006

Debunking Acomplia

Mar 01 2006

The Death of Arcoxia: Drug Regulation in a "Whistleblower" Climate

May 01 2007

FDA's Drug Safety Changes: Safe Legislation; Unsafe Climate

Jan 01 2007

Positioning Acomplia: Has the Drug Arrived Before the Disease?

Nov 01 2005

Sanofi's Acomplia Stumbles

Mar 01 2006

Related Companies

Merck & Co., Inc.

Sanofi

Additional Topics

Leadership Regulation BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window